Washington University School of Medicine, St Louis, MO.
Washington University School of Medicine, St Louis, MO.
Am J Obstet Gynecol. 2018 Feb;218(2):200-210.e1. doi: 10.1016/j.ajog.2017.09.017. Epub 2017 Sep 23.
The objective of the study was to assess the effect of prophylactic negative-pressure wound therapy on surgical site infections and other wound complications in women after cesarean delivery.
We searched Ovid Medline, Embase, SCOPUS, Cochrane Database of Systematic Reviews, and ClinicalTrials.gov.
We included randomized controlled trials and observational studies comparing prophylactic negative-pressure wound therapy with standard wound dressing for cesarean delivery.
The primary outcome was surgical site infection after cesarean delivery. Secondary outcomes were composite wound complications, wound dehiscence, wound seroma, endometritis, and hospital readmission. Heterogeneity was assessed using Higgin's I. Relative risks with 95% confidence intervals were calculated using random-effects models.
Six randomized controlled trials and 3 cohort studies in high-risk mostly obese women met inclusion criteria and were included in the meta-analysis. Six were full-text articles, 2 published abstracts, and 1 report of trial results in ClinicalTrials.gov. Studies were also heterogeneous in the patients included and type of negative-pressure wound therapy device. The risk of surgical site infection was significantly lower with the use of prophylactic negative-pressure wound therapy compared with standard wound dressing (7 studies: pooled risk ratio, 0.45; 95% confidence interval, 0.31-0.66; adjusted risk ratio, -6.0%, 95% confidence interval, -10.0% to -3.0%; number needed to treat, 17, 95% confidence interval, 10-34). There was no evidence of significant statistical heterogeneity (I = 9.9%) or publication bias (Egger P = .532). Of the secondary outcomes, only composite wound complications were significantly reduced in patients receiving prophylactic negative-pressure wound therapy compared with standard dressing (9 studies: pooled risk ratio, 0.68, 95% confidence interval, 0.49-0.94).
Studies on the effectiveness of prophylactic negative-pressure wound therapy at cesarean delivery are heterogeneous but suggest a reduction in surgical site infection and overall wound complications. Larger definitive trials are needed to clarify the clinical utility of prophylactic negative-pressure wound therapy after cesarean delivery.
本研究旨在评估剖宫产术后预防性使用负压伤口疗法对手术部位感染和其他伤口并发症的影响。
我们检索了 Ovid Medline、Embase、SCOPUS、Cochrane 系统评价数据库和 ClinicalTrials.gov。
纳入比较剖宫产预防性使用负压伤口疗法与标准伤口敷料的随机对照试验和观察性研究。
主要结局为剖宫产术后手术部位感染。次要结局为复合伤口并发症、伤口裂开、伤口血清肿、子宫内膜炎和住院再入院。使用 Higgins I 评估异质性。使用随机效应模型计算相对风险比和 95%置信区间。
纳入了 6 项随机对照试验和 3 项高风险肥胖女性队列研究,并进行了荟萃分析。其中 6 项为全文文章,2 项为摘要发表,1 项为 ClinicalTrials.gov 报告的试验结果。研究在纳入的患者类型和负压伤口治疗设备类型方面也存在异质性。与标准伤口敷料相比,预防性使用负压伤口疗法可显著降低手术部位感染风险(7 项研究:汇总风险比,0.45;95%置信区间,0.31-0.66;调整风险比,-6.0%;95%置信区间,-10.0%至-3.0%;需要治疗的人数,17;95%置信区间,10-34)。无显著统计学异质性(I ² = 9.9%)或发表偏倚(Egger P =.532)。在次要结局中,与标准敷料相比,接受预防性负压伤口疗法的患者仅复合伤口并发症显著降低(9 项研究:汇总风险比,0.68;95%置信区间,0.49-0.94)。
剖宫产预防性使用负压伤口疗法的有效性研究存在异质性,但提示可降低手术部位感染和总体伤口并发症发生率。需要更大规模的确定性试验来阐明剖宫产术后预防性使用负压伤口疗法的临床实用性。